PharmaShots | Incisive News in 3 Shots

Subscribe Now

22F

Merck's V114 Receives FDA's Breakthrough Therapy Designation to Prevent Invasive Pneumococcal Disease

Merck's V114 Receives FDA's Breakthrough Therapy Designation to Prevent Invasive Pneumococcal Disease

January 31, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us